Skip to main content
SENATE 1437116th CongressRead twice and referred to the Committee on Finance. (text: CR S2791)

Drug-price Transparency in Communications (DTC) Act

Last Action
5/13/2019

Actions

  • 2019-05-13Read twice and referred to the Committee on Finance. (text: CR S2791)
  • 2019-05-13Introduced in Senate

CRS Summary

As of 2019-05-13 (00)

Drug-price Transparency in Communications (DTC) Act

This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.

Subjects

  • Consumer affairs
  • Health care costs and insurance
  • Inflation and prices
  • Marketing and advertising
  • Medicaid
  • Medicare
  • Prescription drugs
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.